PISCATAWAY, NJ - — Dr. Muhammed Majeed, President and founder of Sabinsa Corporation, announces that the company has been assigned a patent for Citrin® K. The US patent #5,783,603, dated July 21, 1998 is entitled "Potassium hydroxycitrate for the suppression of appetite and induction of weight loss."

Sabinsa offers Citrin® K in a standardized powdered extract and in a standardized liquid. Citrin® K offers a wider array of applications for this popular weight loss ingredient, as an addition to beverages for example.

Hydroxycitric acid (RCA) was first made available in the US by Sabinsa Corporation in 1991 under the trademarked name Citrin®. Citrin®, the first all natural derivative of Garcinia cambogia ever introduced to the US and world markets, has been shown through independent laboratory analysis to contain the highest percentage of lactone-free hydroxycitric acid.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufacturers and supplies quality assured phytonutrients, standardized herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key staff.